Samiksha Jaiswal

Andarine

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
ATC code  none
PubChem CID  9824562
Molar mass  441.357 g/mol
CAS Number  401900-40-1
IUPHAR/BPS  7849
Andarine wwwsarmstore1comwpcontentuploads201509s4a
Legal status  US: Investigational New Drug
Synonyms  Acetamidoxolutamide; Androxolutamide; GTx-007; S-4

Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.

Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.

References

Andarine Wikipedia


Similar Topics
Dharmapuri (film)
Kunal Basu
Eugene Scalia
Topics